Are Dividend Giants BHP Billiton plc, GlaxoSmithKline plc And HSBC Holdings plc Worth A Buy?

Are Dividend Giants BHP Billiton plc (LON:BLT), GlaxoSmithKline plc (LON:GSK) And HSBC Holdings plc (LON:HSBA) Worth A Buy?

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

These dividend giants all pay out huge yields that are great for any portfolio. As you can see in the table below all three companies pay more than 6% dividend yield against a FTSE 100 average yield of 4%. Income stocks are becoming a popular addition to many portfolios and should be part of every investor’s research. The three companies listed below are some of the UK’s most popular stocks. 

  Dividend
Yield
Dividend
Cover
BHP 11.7% 0.4
GlaxoSmithKline 6.17% 0.83
HSBC 6.3% 1.58

BHP Billiton

BHP Billiton (LSE: BLT), like many other commodity-based companies, has had a year to forget. Commodity prices are falling ever lower and the company has recently had an environmental disaster in Brazil where 13 people died in a dam burst. The company pays a huge dividend that is coming under threat due to declining revenues and a possible $3.5bn fine for the dam burst in Brazil. 

The dividend cover of 0.4 is less than reassuring, too, and commodity prices don’t look like shooting higher any time soon. Investors that buy the shares now and hold for the long term may well be rewarded well, but should expect short term pain first. 

GlaxoSmithKline

GlaxoSmithKline’s (LSE: GSK) share price has also been under increased pressure, due to blockbuster drugs coming off patent. This has come as a slight surprise to many, as Glaxo has an exiting pipeline of new drugs that should boost company earnings and fill the earnings gap. City analysts forecast strong earnings growth in 2016 and 2017, which should also give strength to its dividend.

At a current yield of 6.1% it looks a solid bet for the next few years, with big growth prospects for such a large company. 

HSBC

HSBC (LSE: HSBA) currently has a P/E ratio of just over 9.5, which implies the company is undervalued and has scope for growth. This growth should be provided by HSBC’s emerging market business and 2016 looks like it may be a good year in these emerging countries. China and India have both had good growth numbers come out in the last few weeks which is encouraging. The company has also identified billions worth of savings that should do wonders for the bank going forward. 

The three companies listed here all offer various risk profiles that should always be taken into account before investing. BHP is the ‘higher risk’ company, due to the declining commodities environment, and its dividend may well have to be cut to conserve cash. It does however offer the highest yield in the FSTE 100,  so for brave investors that believe in the company this could well be the buying opportunity of the decade. GlaxoSmithKline and HSBC are ‘lower risk’ plays, offering solid income with growth prospects too. 

Jack Dingwall has no position in any shares mentioned. The Motley Fool UK has recommended GlaxoSmithKline and HSBC Holdings. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Finger clicking a button marked 'Buy' on a keyboard
Investing Articles

Why is everyone buying Rolls-Royce shares?

Rolls-Royce shares jumped 10% today, even giving mining stocks a run for their money as the FTSE 100 index suddenly…

Read more »

Shot of a senior man drinking coffee and looking thoughtfully out of a window
Investing Articles

Up 8%: what’s going on with Lloyds shares today?

Dr James Fox takes a closer look at one of the stock market's biggest gainers on Wednesday 8 April after…

Read more »

piggy bank, searching with binoculars
Investing Articles

Fresnillo share price rebounds as a FTSE 100 top mover after a 30% sell-off — what’s next?

The Fresnillo share price has surged today — Andrew Mackie asks whether this FTSE 100 mover is signalling a turning…

Read more »

Artillery rocket system aimed to the sky and soldiers at sunset.
Investing Articles

The BP and Shell share price are being hammered today – what should investors do?

FTSE 100 stocks are rocketing this morning but the BP and Shell share price are heading the other way. Should…

Read more »

Man hanging in the balance over a log at seaside in Scotland
Investing Articles

Has the BP share price rally just run out of steam?

Andrew Mackie looks beyond today’s BP share price fall to explain why cash flow and the oil cycle still support…

Read more »

Happy woman commuting on a train and checking her mobile phone while using headphones
Investing Articles

Barclays shares surge: stick or twist?

Barclays shares surged on Wednesday after the US and Iran announced a ceasefire agreement for two weeks. But there's more…

Read more »

A pastel colored growing graph with rising rocket.
Investing Articles

What would £10,000 invested in Aviva shares 5 years ago be worth today?

Aviva shares have outperformed the FTSE 100 over the past five years. And the dividends have been impressive too. But…

Read more »

Senior couple crossing the road on a city street. They are walking with shopping bags while Christmas shopping.
Investing Articles

Could these 8 FTSE 250 shares turn £20,000 into £297,276 within 25 years?

James Beard reckons it’s possible to use dividend shares to create long-term wealth. But could his strategy work with these…

Read more »